Ophthalmic Plast Reconstr Surg
Dr. James C. Fleming, MD
NPI1477510857
- Medicare services, 2018
- 9,590
- Part D claims, 2018
- 295
- Publications
- 40
- Clinical trials
- 2
- Industry payments
- $13,978
- Practice address
- 262 Danny Thomas Place, Memphis, TN 38105
- Practice phone
- Call (901) 495-3300
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Fleming's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. James C. Fleming is an ophthalmologist in Memphis, Tennessee
Dr. Fleming practices at St. Jude Children's Research Hospital in Memphis, Tennessee, part of St. Jude Childrens Research Hospital.
Dr. Fleming's NPI, 1477510857, was assigned on April 28, 2006. Dr. Fleming holds Tennessee license 9128.
NPI and contact details
- NPI
- 1477510857NPI Registry (opens in a new tab)
- NPI enumeration date
- April 28, 2006
- NPI status
- Active
- Practice phone
- (901) 495-3300
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. James C. Fleming practices at St. Jude Children's Research Hospital in Memphis, Tennessee
Dr. Fleming's primary practice is St. Jude Children's Research Hospital, at 262 Danny Thomas Place, Memphis, TN 38105 in Shelby County. The practice phone is (901) 495-3300.
- St. Jude Children's Research Hospital262 Danny Thomas Place, Memphis, TN 38105 · Shelby CountyPhone(901) 495-3300
Source: Dmand AI Affiliation Data
Dr. James C. Fleming is affiliated with 2 medical groups
Dr. Fleming's primary practice is St. Jude Children's Research Hospital in Memphis, Tennessee, part of St. Jude Childrens Research Hospital. The medical group on file is St. Jude Children's Research Hospital. Dmand AI also links Dr. Fleming to 1 more medical group, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. James C. Fleming's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fleming practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| St. Jude Children's Research Hospital | Available with a free account |
| +1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Fleming practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across St. Jude Childrens Research Hospital and 6.2K+ hospitals, with verified contacts in the same login.
Dr. James C. Fleming is one of 310 ophthalmologists in Tennessee
Ophthalmology is Dr. Fleming's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Fleming is licensed in Tennessee.
Specialties and state licenses
- Ophthalmology, TennesseePrimary
Ophthalmologists near Dr. Fleming
Counts of ophthalmologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. James C. Fleming billed Medicare for 9,590 services in 2018
CMS data shows 9,590 Medicare services from Dr. Fleming across 20 procedure codes in 2018. Medicare paid $156,195 for them.
Medicare services, 20189,590
Paid by Medicare$156,195
Procedure codes20
Dr. Fleming's Medicare services by type, 2017 to 2018
- 2017
- 2018
- Drugs given in the office
- 2017: 8,9222018: 8,6443%
- Tests and treatments
- 2017: 6352018: 6124%
- Surgery
- 2017: 3842018: 33413%
- Office and hospital visits
- 2017: 502018: 0100%
Where Dr. Fleming's Medicare services took place, 2018
- In an office9,44498%
- In a facility1452%
Dr. Fleming compared with the Tennessee median for ophthalmologists, 2018
- Dr. Fleming
- Tennessee median
- Medicare services
- 9,590vs 1,5846.1 times
- Part D claims
- 295vs 63353% below
Medians across 333 ophthalmologists in Tennessee with Dmand AI profiles that report each measure.
Dr. Fleming's most billed Medicare procedure codes, 2018
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Fleming?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Fleming and other ophthalmologists in Tennessee.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. James C. Fleming's patients have a median age of 18
Across all payers, Dmand AI patient panel data puts Dr. Fleming's median patient age at 18, with 45% women.
Dr. Fleming's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 18
Patient panel by sex, all payers
- Women45%
- Men53%
Source: Dmand AI Patient Panel Data
Dr. James C. Fleming wrote 295 Medicare Part D claims in 2018
In 2018, Dr. Fleming wrote 295 Medicare Part D claims. They cover 5 drugs, with $8,906 in total drug cost. In 2017, CMS named 271 claims across 3 drugs.
Part D claims, 2018295
Drugs named by CMS5
Total drug cost$8,906
Dr. Fleming's most prescribed drugs by claims, 2018
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2017 to 2018
- 2017
- 2018
- Claims for drugs CMS names
- 2017: 2712018: 2959%
Drugs named by CMS: 5 in 2018, 3 in 2017.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find ophthalmologists like Dr. Fleming by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. James C. Fleming has 40 publications on record
Dmand AI links 40 papers to Dr. Fleming, published from 2011 to 2025. 2017 was the busiest year, with 3. The most frequent topics are Ophthalmologic Surgical Procedures, Tomography, X-Ray Computed and Orbit. Dr. Fleming has published most often in Ophthalmic Plast Reconstr Surg. Dr. Fleming's most frequent co-authors are Brian T. Fowler, MD, Stephen Dryden, MD and Andrew Gordon Meador, MD.
Papers40
Years published2011 to 2025
Dr. Fleming's papers by year, 2015 to 2025
Topics Dr. Fleming writes about most
- Ophthalmologic Surgical Procedures
- Tomography, X-Ray Computed
- Orbit
- Orbital Diseases
- Blepharoptosis
- Cadaver
- Compartment Syndromes
- Eye
Dr. Fleming's most frequent co-authors
- Brian T. Fowler, MD26 shared papers
- Stephen Dryden, MD14 shared papers
- Andrew Gordon Meador, MD8 shared papers
Recent publications by Dr. Fleming
Ophthalmic Plast Reconstr Surg
CadaverCompartment SyndromesEyelids
Ophthalmic Plast Reconstr Surg
Decompression, SurgicalIntraocular PressureOrbit
See who Dr. Fleming researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Fleming works with, so you can find a warm path to the right ophthalmologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. James C. Fleming has worked on 2 clinical trials
Dmand AI links Dr. Fleming to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Graves Ophthalmopathy and Exophthalmos. Amgen sponsors the most, 2.
Conditions in Dr. Fleming's trials
- Graves Ophthalmopathy
- Exophthalmos
Investigators on the most trials with Dr. Fleming
- Roger Allan Dailey, MD2 shared trials
- Raymond S. Douglas, MD, PhD2 shared trials
- Gerald J. Harris, MD2 shared trials
Recent clinical trials with Dr. Fleming
Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study (opens in a new tab)
CompletedPhase 3
Graves OphthalmopathyExophthalmosTeprotumumab
Graves OphthalmopathyExophthalmosTeprotumumab
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. James C. Fleming received $13,978 in industry payments from 2016 to 2024
CMS Open Payments shows 26 general payments to Dr. Fleming from 11 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 34% of the total. Synthes GmbH paid the most, $13,339.
General payments to Dr. Fleming by program year, 2016 to 2024
General payments to Dr. Fleming by kind, 2016 to 2024
$14Kin total
- Travel and lodging$4,79034%
- Compensation for serving as faculty or as a speaker for a medical education program$4,00029%
- Accredited education speaker fees$4,00029%
- Food and beverage$1,1508%
- Education$380%
Companies that paid Dr. Fleming the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. James C. Fleming's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. James C. Fleming
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. James C. Fleming's NPI number?
Dr. James C. Fleming's NPI number is 1477510857. It was assigned on April 28, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. James C. Fleming?
Dr. James C. Fleming is an ophthalmologist in Memphis, Tennessee. The primary specialty in the NPI Registry is Ophthalmology Physician (taxonomy code 207W00000X).
Where does Dr. James C. Fleming practice?
Dr. Fleming practices at 262 Danny Thomas Place, Memphis, TN 38105. Dr. Fleming's primary practice is St. Jude Children's Research Hospital in Memphis, Tennessee, part of St. Jude Childrens Research Hospital. Dmand AI also links Dr. Fleming to 1 medical group.
What is Dr. James C. Fleming's office phone number?
The practice phone on file for Dr. Fleming is (901) 495-3300.
What is Dr. James C. Fleming's medical license number?
Dr. Fleming holds Tennessee license 9128.
Which hospitals is Dr. James C. Fleming affiliated with?
Dr. Fleming practices at St. Jude Children's Research Hospital in Memphis, Tennessee.
What medical group is Dr. James C. Fleming part of?
Dr. Fleming is linked to St. Jude Children's Research Hospital. Dmand AI links Dr. Fleming to 1 more medical group.
Does Dr. James C. Fleming accept Medicare?
Yes. CMS data shows Dr. Fleming billed Medicare for 9,590 services in 2018.
What services does Dr. James C. Fleming bill to Medicare?
In 2018, Dr. Fleming's most billed Medicare services were injected or infused drug (J0585), eye exam or test (92012) and surgery: brain, spine and nerves (64612).
What drugs does Dr. James C. Fleming prescribe most?
In 2018 Medicare Part D data, Dr. Fleming's most prescribed drugs by claims were Erythromycin, Hydrocodone-Acetaminophen and Neomycin-Polymyxin-Dexameth.
Show 4 more questionsShow fewer questions
Has Dr. James C. Fleming received payments from drug or device companies?
CMS Open Payments shows $13,978 in general payments to Dr. Fleming from 11 companies from 2016 to 2024. The largest total came from Synthes GmbH.
How long has Dr. James C. Fleming been practicing?
Dr. Fleming's NPI was assigned in 2006.
Does Dr. James C. Fleming do research?
Dmand AI links 40 publications to Dr. Fleming, published from 2011 to 2025. Dr. Fleming has worked on 2 clinical trials.
Who does Dr. James C. Fleming publish with?
Dr. Fleming's most frequent co-authors are Brian T. Fowler, MD (26 shared papers), Stephen Dryden, MD (14 shared papers) and Andrew Gordon Meador, MD (8 shared papers).
Selling to ophthalmology practices?
See ophthalmologists in Tennessee by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card